DexCom Inc.
Patent owner in reexamination·3 ex parte reexams
DexCom Inc.'s patents have been the subject of 3 USPTO ex parte reexaminations. Its patents are most often challenged by Abbott Diabetes Care Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top requesters
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/012,628 | Sep 14, 2012 | 6,702,857 | Membrane for Use with Implantable Devices | — | Closed |
| 90/012,631 | Sep 14, 2012 | 7,835,777 | DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS | — | Closed |
| 90/012,558 | Sep 13, 2012 | 7,310,544 | Methods and Systems for Inserting a Transcutaneous Analyte Sensor | Abbott Diabetes Care Inc. | Closed |
See the full reexam picture for DexCom Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.